AARD aardvarktherapeutics.com Net earnings per share for the last 12 months

Public company logo of Aardvark Therapeutics Inc (AARD)

The rolling trailing twelve-month earnings per share accounts for R&D expenses and the anticipation of clinical trial results, with the -3.33 value serving as the target level. Aardvark Therapeutics Inc (AARD) possesses a scientific reputation in the treatment of obesity. The company's revenues rely on future sales of drugs for patients with Prader-Willi syndrome through government funds and insurance systems.

AARD (Aardvark Pharma) Net earnings per share (EPS TTM) history from 02/14/2025 to 11/18/2026

Analytical breakdowns and data insights for company Aardvark Pharma (AARD)

- stock price and consensus target price:
Fundamental company valuation:Aardvark Therapeutics Inc. (AARD)
Mass-produced product of Aardvark Therapeutics Corp

Analyzing the 12-month net income per share chart allows for an assessment of the management efficiency of the innovative biotech asset Aardvark Therapeutics Inc (AARD) within the metabolic disorder therapy segment. This indicator reflects the final income distributed per share, enabling investors to evaluate the sustainability of the business model and the financial strength of Aardvark Therapeutics Inc (AARD) through profit dynamics amidst ongoing clinical trials.

Competitors of Aardvark Therapeutics Inc

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx Corp|Rezolute Bio (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months lexpharma.com (LXRX)|Net earnings per share for the last 12 months MBX Biosciences Inc MBX|Earnings per share for the last twelve months Altimmune ALT|Net earnings per share for the last four quarters Sagimet Biosciences Inc. (SGMT)|BioAge Labs, Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Biomea Fusion Corp BMEA|QNCX: Net earnings per share (EPS TTM)|Fractyl Health, Inc. (GUTS) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months VTVT|Agape ATP Corporation - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PLUR|SYBX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) LPCN (lipocine.com)|Net earnings per share (EPS TTM) Matinas BioPharma MTNB|SPRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Galecto Corp|CTCX (Carmell Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS